Table 2.
Paradigm | Synopsis | Citations |
---|---|---|
Osteoclast-mediated toxicity | Bisphosphonates suppress osteoclast-mediated bone remodeling. This suppression results in “fatigue” of the alveolar bone, responsible for necrosis | [83–85] |
| ||
Soft tissue toxicity | The oral mucosa is initially involved. As the damage progresses, underlying alveolar bone is also involved and the clinical presentation of ONJ becomes evident | [79, 86] |
| ||
Infection | Increased bacterial adhesion to the bisphosphonate covered bone may be the cause for ONJ development | [84, 87] |
| ||
Impaired immune homeostasis-macrophage impaired function | Dendritic cells, macrophages, cytotoxic and helper T-lymphocytes are affected by bisphosphonates. Chemokines, like tumor necrosis factor-alpha, inteleukins IL-1a, IL-1b, IL-6 and IL-8 are also impaired by bisphosphonates. Impaired immune response is responsible for continued inflammation resulting in osteomyelitis. Impaired function of macrophages due to RANKL inhibition is a key phenomenon in the defective topical immune response | [79, 88–90] |